Inventor · disambiguated record
Dianne Sako
Also filed as: SAKO DIANNE · SAKO DIANNE S
51 granted patents·26 pending applications·466 citations·filing 1995–2025
98Inventor score
Files withACCELERON PHARMA INC55GENETICS INST5GENETICS INST LLC5WYETH CORP4BRIGHAM & WOMENS HOSPITAL INC3
Top patents by PatentIndex Score
77 records- 0196US9809637B2Transforming growth factor beta receptor II fusion polypeptidesACCELERON PHARMA INC·Filed 2016·Granted Nov 7, 2017·19 cites·9 claims
- 0295US5827817AP-selectin ligand proteinGENETICS INST·Filed 1995·Granted Oct 27, 1998·146 cites·16 claims
- 0393US11028145B2ALK7:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Jun 8, 2021·4 cites·23 claims
- 0493US10358476B2Single arm type I and type II receptor fusion proteins and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Jul 23, 2019·12 cites·16 claims
- 0593US10227393B2TGF-beta superfamily type I and type II receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Mar 12, 2019·9 cites·27 claims
- 0692US5840679AMethod of inhibiting P-selectin ligand activityGENETICS INST·Filed 1995·Granted Nov 24, 1998·98 cites·26 claims
- 0791US11279746B2ALK4:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2020·Granted Mar 22, 2022·2 cites·11 claims
- 0891US10738098B2ALK4:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2018·Granted Aug 11, 2020·6 cites·33 claims
- 0990US10501547B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2017·Granted Dec 10, 2019·3 cites·7 claims
- 1089US10906958B2TGF-beta superfamily type I and type II receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Feb 2, 2021·2 cites·4 claims
- 1188US7563760B2P-selectin ligand proteinGENETICS INST LLC·Filed 2001·Granted Jul 21, 2009·23 cites·16 claims
- 1287US10307455B2Activin type 2 receptor antibodiesACCELERON PHARMA INC·Filed 2017·Granted Jun 4, 2019·5 cites·14 claims
- 1387US5843707ANucleic acid encoding a novel P-selectin ligand proteinGENETICS INST·Filed 1995·Granted Dec 1, 1998·71 cites·27 claims
- 1487US2024158468A1Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2023·Application pending·0 cites
- 1586US10316076B2Transforming growth factor-beta receptor type II fusion polypeptidesACCELERON PHARMA INC·Filed 2017·Granted Jun 11, 2019·3 cites·19 claims
- 1686US10227392B2ALK7:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Mar 12, 2019·3 cites·29 claims
- 1786US10196434B2ALK4:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2016·Granted Feb 5, 2019·3 cites·31 claims
- 1886US9975934B2Follistatin-related fusion proteinsACCELERON PHARMA INC·Filed 2016·Granted May 22, 2018·3 cites·28 claims
- 1985US2024374671A1Activin Type 2 Receptor Binding Proteins and Methods of Making ThemACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 2084US11951156B2Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptorBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Granted Apr 9, 2024·1 cites·17 claims
- 2184US2025368720A1Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2025·Application pending·0 cites
- 2284US2024309098A1Alk7 antagonists and uses thereofACCELERON PHARM INC·Filed 2024·Application pending·0 cites
- 2383US11059894B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2019·Granted Jul 13, 2021·1 cites·7 claims
- 2483US10682392B2Methods for treating pulmonary hypertension with a TGF-beta type II receptor-FC fusion proteinBRIGHAM & WOMENS HOSPITAL INC·Filed 2014·Granted Jun 16, 2020·4 cites·11 claims
- 2583US7252820B2Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereofGENETICS INST LLC·Filed 2005·Granted Aug 7, 2007·4 cites·38 claims
- 2683US2025109184A1Tgf-beta receptor type ii fusion proteins and uses thereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 2782US12258380B2ALK4:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2022·Granted Mar 25, 2025·0 cites·20 claims
- 2882US2023416379A1ALK7 Binding Proteins and Uses ThereofACCELERON PHARMA INC·Filed 2023·Application pending·0 cites
- 2980US11440949B2TGF-beta superfamily type I and type II receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2017·Granted Sep 13, 2022·1 cites·15 claims
- 3080US6277975B1Fusions of P-selectin ligand protein and polynucleotides encoding sameGENETICS INST·Filed 1996·Granted Aug 21, 2001·34 cites·16 claims
- 3179US12421295B2TGF-beta superfamily type I and type II receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2022·Granted Sep 23, 2025·0 cites·11 claims
- 3279US11001614B2Method for treating a muscle-related disorder with follistatin-related fusion proteinsACCELERON PHARMA INC·Filed 2018·Granted May 11, 2021·1 cites·28 claims
- 3379US2025197469A1Alk4:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2025·Application pending·0 cites
- 3478US12024563B2ALK7 antagonists and uses thereofACCELERON PHARMA INC·Filed 2021·Granted Jul 2, 2024·0 cites·12 claims
- 3578US11827689B2ALK7:ActRIIB heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2021·Granted Nov 28, 2023·0 cites·21 claims
- 3678US2024366720A1Compositions and methods for treating pulmonary hypertensionBRIGHAM & WOMENS HOSPITAL INC·Filed 2024·Application pending·0 cites
- 3777US12145970B2Twisted gastrulation polypeptides and uses thereofACCELERON PHARMA INC·Filed 2023·Granted Nov 19, 2024·0 cites·12 claims
- 3877US11708414B2ALK7 binding proteins and uses thereofACCELERON PHARMA INC·Filed 2021·Granted Jul 25, 2023·0 cites·7 claims
- 3977US2025084388A1Alk4:actriib heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 4076US12195519B2Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptidesACCELERON PHARMA INC·Filed 2021·Granted Jan 14, 2025·0 cites·35 claims
- 4176US12042524B2Activin type 2 receptor binding proteins methods of making themACCELERON PHARMA INC·Filed 2021·Granted Jul 23, 2024·0 cites·15 claims
- 4276US2021230252A1Tgf-beta receptor type ii variants and uses thereofACCELERON PHARMA INC·Filed 2021·Application pending·0 cites
- 4375US2024287196A1ALK7 Binding Proteins and Uses ThereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 4474US6881404B2Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same and related proteases, and therapeutic uses thereofINST GENETICS LLC·Filed 2001·Granted Apr 19, 2005·4 cites·45 claims
- 4574US2022396607A1Tgf-beta superfamily type i and type ii receptor heteromultimers and uses thereofACCELERON PHARMA INC·Filed 2020·Application pending·0 cites
- 4674US2025333477A1Novel binders of tgfb-superfamily ligands and uses thereofACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 4773US11008377B2Methods of treating a fibrotic disorder by administering transforming growth factor beta receptor II fusion polypeptidesACCELERON PHARMA INC·Filed 2020·Granted May 18, 2021·0 cites·16 claims
- 4873US10981973B2Methods of treating a sclerotic disorder by administering a transforming growth factor beta receptor type II fusion polypeptideACCELERON PHARMA INC·Filed 2019·Granted Apr 20, 2021·0 cites·17 claims
- 4973US2025109179A1MULTISPECIFIC BINDERS OF TGFBeta-SUPERFAMILY LIGANDS AND USES THEREOFACCELERON PHARMA INC·Filed 2024·Application pending·0 cites
- 5071US11000565B2Methods of increasing muscle mass by administration of activin type 2 receptor antibodiesACCELERON PHARMA INC·Filed 2019·Granted May 11, 2021·0 cites·10 claims
Showing the top 50 of 77 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →